Priscila Z. Ramos
Campinas, SP 13083886, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Discovery and Characterization of Cell-Permeable Inhibitors of Leishmania mexicana CLK1 Using an In-Cell Target Engagement Assay.
Journal: ACS infectious diseases
Published: September 25, 2025
Target engagement in bacterial and protozoan pathogens: in vitro and cellular assays for drug discovery.
Journal: Current opinion in structural biology
Published: August 30, 2025
Hit-to-Lead Studies of Pyrazinylpiperazines against Visceral Leishmaniasis: Pharmacokinetic Profile and In Vivo Efficacy of Potent Compounds against Leishmania infantum.
Journal: ACS pharmacology & translational science
Published: April 29, 2025
Novel Dihydropteridinone Derivatives As Potent Inhibitors of the Understudied Human Kinases Vaccinia-Related Kinase 1 and Casein Kinase 1δ/ε.
Journal: Journal of medicinal chemistry
Published: May 23, 2024
Discovery of pyrazolo[3,4-d]pyrimidines as novel mitogen-activated protein kinase kinase 3 (MKK3) inhibitors.
Journal: Bioorganic & medicinal chemistry
Published: October 14, 2023
A Target Engagement Assay to Assess Uptake, Potency, and Retention of Antibiotics in Living Bacteria.
Journal: ACS infectious diseases
Published: July 11, 2022
Discovery of novel benzothiophene derivatives as potent and narrow spectrum inhibitors of DYRK1A and DYRK1B.
Journal: Bioorganic & medicinal chemistry letters
Published: January 31, 2022
Structural features and development of an assay platform of the parasite target deoxyhypusine synthase of Brugia malayi and Leishmania major.
Journal: PLoS neglected tropical diseases
Published: May 18, 2020
Binding and structural analyses of potent inhibitors of the human Ca2+/calmodulin dependent protein kinase kinase 2 (CAMKK2) identified from a collection of commercially-available kinase inhibitors.
Journal: Scientific reports
Published: February 10, 2019
Last Updated: 09/26/2026